COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,248 Articles (22,733 medRxiv, 8,515 bioRxiv)

Most recent first Previous |  Page 519: Articles 5181-5190  | Next

Unique amino acid substitution in RBD region of SARS-CoV-2 Omicron XAY.2
Salsekar, L., Rahangdale, S., Tamboli, E., Khairnar, K.
10.1101/2023.01.09.523246 — Posted: 2023-01-09
The Ecology of Viruses in Urban Rodents with a Focus on SARS-CoV-2
Fisher, A., Airey, G., Liu, Y., Gemmell, M., Thomas, J., Bentley, E., Whitehead, M., Paxton, W., Pollakis, G., Paterson, S., Viney, M.
10.1101/2023.01.07.523115 — Posted: 2023-01-09
Bivalent mRNA vaccine improves antibody-mediated neutralization of many SARS-CoV-2 Omicron lineage variants
Jiang, N., Wang, L., Hatta, M., Feng, C., Currier, M., Lin, X., Hossain, J., Cui, D., Mann, B. R., Kovacs, N. A., Wang, W., Atteberry, G., Wilson, M., Chau, R., Lacek, K. A., Paden, C. R., Hassell, N., Rambo-Martin, B., Barnes, J. R., Kondor, R. J., Self, W. H., Rhoads, J. P., Baughman, A., Chappell, J. D., Shapiro, N. I., Gibbs, K. W., Hager, D. N., Lauring, A. S., Surie, D., McMorrow, M. L., Thornburg, N. J., Wentworth, D. E., Zhou, B.
10.1101/2023.01.08.523127 — Posted: 2023-01-09
Effects of Variants of Concern Mutations on the Force-Stability of the SARS-CoV-2:ACE2 Interface and Virus Transmissibility
Bauer, M. S., Gruber, S., Hausch, A., Melo, M. C. R., Gomes, P. S. F. C., Nicolaus, T., Milles, L. F., Bernardi, R. C., Gaub, H. E., Lipfert, J.
10.1101/2023.01.06.522349 — Posted: 2023-01-09
Identification of druggable host dependency factors shared by multiple SARS-CoV-2 variants of concern
Frasson, I., Diamante, L., Zangrossi, M., Carbognin, E., Dalla Pieta, A., Penna, A., Rosato, A., Verin, R., Torrigiani, F., Salata, C., Vaccaro, L., Cacchiarelli, D., Richter, S. N., Montagner, M., Martello, G.
10.1101/2023.01.09.523209 — Posted: 2023-01-09
Differential COVID-19 mortality in the United States: Patterns, causes and policy implications
A Stoto, M. A., Schlageter, S., Gamannossi deglInnocenti, D., Zollo, F., Kraemer, J.
10.1101/2023.01.09.23284358 — Posted: 2023-01-09
Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 infections among healthcare personnel in Pakistan: a test-negative, case-control study.
Khan, U., Hassan, I., Niaz, M., Azam, I., Hasan, Z., Mahmood, F., Ali, A.
10.1101/2023.01.09.23284342 — Posted: 2023-01-09
Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: Results from the COViK study
Stoliaroff, A., Peine, C., Herath, T., Lachmann, J., Hellenbrand, W., Perriat, D., Doerre, A., Nitsche, A., Michel, J., Grossegesse, M., Hofmann, N., Rinner, T., Kohl, C., Brinkmann, A., Meyer, T., Stern, D., Treindl, F., Dorner, B. G., Hein, S., Werel, L., Hildt, E., Glaeser, S., Schuehlen, H., Isner, C., Peric, A., Ghouzi, A., Reichardt, A., Janneck, M., Lock, G., Huster, D., Gruenewald, T., Schaade, L., Wichmann, O., Harder, T.
10.1101/2023.01.09.23284327 — Posted: 2023-01-09
The effect of previous SARS-CoV-2 infection and COVID-19 vaccination on SARS-CoV-2 Omicron infection and relation with serological response - a prospective cohort study
de Gier, B., Huiberts, A. J., Hoeve, C. E., den Hartog, G., van Werkhoven, H. C. H., van Binnendijk, R., Hahne, S. J. M., de Melker, H. E., van den Hof, S., Knol, M. J.
10.1101/2023.01.09.23284334 — Posted: 2023-01-09
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from 12 July 2021 to 6 June 2022: a prospective cohort study
Huiberts, A. J., de Gier, B., Hoeve, C. E., de Melker, H. E., Hahne, S. J. M., den Hartog, G., Grobbee, D. E., van de Wijgert, J. H. H. M., van den Hof, S., Knol, M. J.
10.1101/2023.01.09.23284335 — Posted: 2023-01-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).